BioNTech To Price Vaccine Below Market Rates, Differentiate Between Regions

BioNTech, first in the race to produce evidence of a working COVID19 vaccine, is planning to price the twoshot regimen below "typical market rates" and would differentiate pricing between countries or regions.

from Top Business News- News18.com https://ift.tt/3keRnyQ

• Tweet
• Share
• Share
• Share
• Share